Antivirals and Drug Resistance in Microbiology
Antivirals and drug resistance
Antiviral agents: Mechanism of action of Amantadine, Acyclovir,
Azidothymidine
Antibiotic resistance, MDR, XDR, MRSA, NDM-1.
•
First line drugs : eg
TB can be treated effectively by using (FLD)
isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), ethambutol (EMB)
and streptomycin (SM).
•
Second line drugs
are the TB
drugs
that are used for
the
treatment
of
drug
resistant TB. The
second line drugs
include
levofloxacin, moxifloxacin, bedaquiline, delamanid and linezolid.
•
Third
-
line
: newer generation drugs eg NNRTIs like etravirine (ETV),
boosted PIs like ritonavir boosted darunavir (DRV/r), and integrase
inhibitor raltegravir (RAL)
•
Multidrug resistance (MDR): pathogens resistant to most of the first line of
defence drugs
•
MD Gram-negative bacteria
(
MDRGN bacteria
) : ESKAPE pathogens
•
Gram-negative bacteria with resistance to multiple antibiotics.
•
Pose a serious and rapidly emerging threat for hospitalized patients particularly
ICUs: correlated with increased morbidity, mortality, and prolonged
hospitalization.
•
Thus, not only do these bacteria pose a threat to global public health, but also
create a significant burden to healthcare systems
•
NDM-1
(New Delhi metallo Beta Lactamase): makes bacteria resistant to a broad
range of beta-lactam antibiotics including the antibiotics of
the carbapenem family, mainly used in the treatment of antibiotic-resistant
bacterial infections.
•
The gene for NDM-1 is one member of a large gene family that encodes beta-
lactamase enzymes called carbapenemases. Bacteria with carbapenemases are
referred to as "superbugs" because infections caused by them are difficult to treat.
Such bacteria are usually sensitive only to polymyxins and tigecycline
•
Methicillin-resistant
Staphylococcus aureus
(
MRSA
) is any strain of
S.
aureus
that has developed, through horizontal gene transfer and natural
selection, multiple drug resistance to beta-lactam
•
MRSA is responsible for several difficult-to-treat infections In humans.
•
MRSA β-lactam antibiotics include some penams (penicillin derivatives such
as methicillin and oxacillin) and cephems such as the cephalosporins. Strains
unable to resist these antibiotics are classified as methicillin-susceptible
S.
aureus
, or MSSA.
•
MRSA : common in hospitals, prisons, and nursing homes, where people with
open wounds, invasive devices such as catheters, and weakened immune
systems are at greater risk of HAIs.
•
MRSA began as a hospital-acquired (HA-MRSA) infection but has become
community-acquired (CA-MRSA), as well as livestock-acquired (LA-MRSA).
•
XDR: extensively drug resistant
” eg Mycobacterium tuberculosis, defined by
resistance to both rifampin and isoniazid, as well as to fluoroquinolones plus an
injectable agent
•
Total drug resistance: resistance to all the available therapeutic options
Antivirals
1.
Amantidine
-
Ion channel
blocker
•
Mode of action
– it prevents the acidification of endosome which prevents
the conformational change in viral membrane , hence preventing fusion of
viral membrane with endosome. In short it prevents secondary uncoating.
•
It also inhibits virus maturation by inhibiting the M2 protein needed in viral
maturation.
•
Rimantidine and Zimantidine has same mode of action just its structure is
different.
•
Analogue of thymidine.
•
is a nucleoside analog reverse transcriptase inhibitor.
•
It was the first approved treatment for HIV
•
Mode of action:- gets phosphorylated in the cells
•
Inhibits HIV DNA synthesis by reverse transcriptase as it lacks 3’OH.
•
easily enters the cell as it more lipophillic due presence of azido group.
•
Sometimes get integrated in cellular DNA, but it inhibits RT more
efficiently.
3)AZT(azidothymidine)
:-
•
Better known as
Zidovudine
•
is a
guanosine analogue.
•
used for treating HSV and Herpes zoster infections.
•
it is extremely selective
•
low in cytotoxicity.
•
Pharmacologist Gertrude B. Elion was awarded the
1988 Nobel Prize in Medicine, partly for the
development of aciclovir.
•
Can be used both orally and also topically.
2)
Acyclovir
•
Mode of action:- it contains only a partial nucleoside structure: the
sugar ring is replaced by an open-chain structure.
•
gets
phosphorylated by TK and forms Acyclo-GTP
, ---- a potent
inhibitor of viral DNA polymerase(as it doesn’t have 3’OH)
•
100 times greater affinity for viral than cellular polymerase
•
Gets incorporated into viral DNA, resulting in chain termination
Antiviral agents like Amantadine, Acyclovir, and Azidothymidine, as well as antibiotics, play a crucial role in combating drug resistance. The emergence of multidrug-resistant pathogens, such as MRSA, NDM-1, and XDR strains, presents challenges in treatment. Various drug categories from first-line to third-line drugs are utilized to address different levels of resistance, with a focus on treating conditions like tuberculosis and infections caused by resistant bacteria.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Antivirals and drug resistance Antiviral agents: Mechanism of action of Amantadine, Acyclovir, Azidothymidine Antibiotic resistance, MDR, XDR, MRSA, NDM-1.
First line drugs : eg TB can be treated effectively by using (FLD) isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), ethambutol (EMB) and streptomycin (SM). Second line drugs are the TB drugs that are used for the treatment of drug resistant TB. The second line drugs include levofloxacin, moxifloxacin, bedaquiline, delamanid and linezolid. Third-line : newer generation drugs eg NNRTIs like etravirine (ETV), boosted PIs like ritonavir boosted darunavir (DRV/r), and integrase inhibitor raltegravir (RAL)
Multidrug resistance (MDR): pathogens resistant to most of the first line of defence drugs MD Gram-negative bacteria (MDRGN bacteria) : ESKAPE pathogens Gram-negative bacteria with resistance to multiple antibiotics. Pose a serious and rapidly emerging threat for hospitalized patients particularly ICUs: correlated with increased morbidity, mortality, and prolonged hospitalization. Thus, not only do these bacteria pose a threat to global public health, but also create a significant burden to healthcare systems NDM-1 (New Delhi metallo Beta Lactamase): makes bacteria resistant to a broad range of beta-lactam antibiotics including the antibiotics of the carbapenem family, mainly used in the treatment of antibiotic-resistant bacterial infections. The gene for NDM-1 is one member of a large gene family that encodes beta- lactamase enzymes called carbapenemases. Bacteria with carbapenemases are referred to as "superbugs" because infections caused by them are difficult to treat. Such bacteria are usually sensitive only to polymyxins and tigecycline
Methicillin-resistant Staphylococcus aureus (MRSA) is any strain of S. aureus that has developed, through horizontal gene transfer and natural selection, multiple drug resistance to beta-lactam MRSA is responsible for several difficult-to-treat infections In humans. MRSA -lactam antibiotics include some penams (penicillin derivatives such as methicillin and oxacillin) and cephems such as the cephalosporins. Strains unable to resist these antibiotics are classified as methicillin-susceptible S. aureus, or MSSA. MRSA : common in hospitals, prisons, and nursing homes, where people with open wounds, invasive devices such as catheters, and weakened immune systems are at greater risk of HAIs. MRSA began as a hospital-acquired (HA-MRSA) infection but has become community-acquired (CA-MRSA), as well as livestock-acquired (LA-MRSA). XDR: extensively drug resistant eg Mycobacterium tuberculosis, defined by resistance to both rifampin and isoniazid, as well as to fluoroquinolones plus an injectable agent Total drug resistance: resistance to all the available therapeutic options
Antivirals Amantidine - Ion channel blocker 1. Mode of action it prevents the acidification of endosome which prevents the conformational change in viral membrane , hence preventing fusion of viral membrane with endosome. In short it prevents secondary uncoating. It also inhibits virus maturation by inhibiting the M2 protein needed in viral maturation. Rimantidine and Zimantidine has same mode of action just its structure is different.
3)AZT(azidothymidine) :- Better known as Zidovudine Analogue of thymidine. is a nucleoside analog reverse transcriptase inhibitor. It was the first approved treatment for HIV Mode of action:- gets phosphorylated in the cells Inhibits HIV DNA synthesis by reverse transcriptase as it lacks 3 OH. easily enters the cell as it more lipophillic due presence of azido group. Sometimes get integrated in cellular DNA, but it inhibits RT more efficiently.
2) Acyclovir is a guanosine analogue. used for treating HSV and Herpes zoster infections. it is extremely selective low in cytotoxicity. Pharmacologist Gertrude B. Elion was awarded the 1988 Nobel Prize in Medicine, partly for the development of aciclovir. Can be used both orally and also topically.
Mode of action:- it contains only a partial nucleoside structure: the sugar ring is replaced by an open-chain structure. gets phosphorylated by TK and forms Acyclo-GTP , ---- a potent inhibitor of viral DNA polymerase(as it doesn t have 3 OH) 100 times greater affinity for viral than cellular polymerase Gets incorporated into viral DNA, resulting in chain termination
